Biographical
Sketches of NIAID
Council Members
NIAID welcomes our new Council members for 2010: Connie Celum, Nelson Chao, George Siber, and Jenny Ting.
Senior Staff
- Chairperson: Anthony S. Fauci, M.D., Director, NIAID, NIH, DHHS
- Executive secretary: Marvin R. Kalt, Ph.D., Director, DEA,
NIAID, NIH, DHHS
- Ex officio members:
- Francis S. Collins, M.D., Ph.D., Director, NIH, DHHS
- Other ex officio members are listed beneath their subcommittee.
Acquired Immunodeficiency Syndrome (DAIDS) Subcommittee
| Photo |
Name, Biosketch, and Date Term Ends |
 |
Robert G. Brooks, M.D., is associate dean for health affairs and professor of family medicine and rural health at the Florida State University College of Medicine. He serves on the Florida Governor's Health Information Technology Advisory Board and the Florida Medicaid Reform Advisory Council. Previously, he was chief of infectious diseases at the Orlando Regional Medical Center. He served in the Florida House of Representatives from 1994 until late 1998 when he was appointed Secretary of the Florida Department of Health. (October 31, 2010) |
 |
Carol A. Carter, Ph.D., is professor of molecular genetics and microbiology and adjunct professor of physiology and biophysics at the State University of New York at Stony Brook. She serves as co-chair of graduate admissions for the Stony Brook Program in Molecular Genetics and Microbiology and director of the summer research internship program for undergraduates. Dr. Carter’s major research interest is replication of HIV with a focus on viral assembly and trafficking events required for virus release from infected cells. She is a member of the NIH Etiology and Pathogenesis Planning Committee. (October 31, 2011) |
 |
Connie Celum, M.D., M.P.H., is professor of global health and medicine at the University of Washington and director of the International Clinical Research Center in the Department of Global Health. Her research focuses on clinical trials of biomedical HIV prevention and combination HIV prevention strategies with the objective to find effective strategies to reduce HIV acquisition and transmission. Dr. Celum’s recently completed HIV prevention trials include genital herpes suppression to reduce HIV transmission and disease progression. She is a member of the executive committee of the NIH-funded Microbicides Trials Network. (October 31, 2013)
|
 |
Satya Dandekar, Ph.D., is professor and chair, Department of Internal Medicine at the University of California Davis. Her expertise and research interests are in the areas of HIV/AIDS. She has participated in the review of grant applications and program projects for several committees and has been a reviewer for numerous journals and boards. She has lectured on clinical infectious diseases for professional organizations. (October 31, 2010) |
 |
Louis J. Picker, M.D., is associate director of the Vaccine and Gene Therapy Institute and professor of pathology, molecular microbiology, and immunology at Oregon Health and Science University. He is also the director of the Pathobiology and Immunology Division of the Oregon National Primate Research Center. Dr. Picker’s laboratory focuses on delineating the physiology of T cell memory in primates, mechanisms of protection against persistent pathogens, AIDS vaccine development, and the immunopathogenesis of AIDS-causing lentiviruses. (October 31, 2011) |
 |
Christel H. Uittenbogaart, M.D., is professor of pediatrics and microbiology, immunology, and molecular genetics at the University of California, Los Angeles. Her research focuses on the impact of HIV on the developing immune system and the role of immune activation in HIV pathogenesis. She has served on NIH grant review committees. Dr. Uittenbogaart is the executive director of the Midwinter Conference of Immunologists, an annual conference that communicates the most recent developments in the field of immunology. (October 31, 2011) |
| |
Ex officio member:
- Ronald O. Valdiserri, M.D., M.P.H., Chief Consultant, Public Health Strategic Health Care Group, U.S. Department of Veterans Affairs
|
Allergy and Immunology (DAIT) Subcommittee
| Photo |
Name, Biosketch, and Date Term Ends |
 |
Nelson J. Chao, M.D., M.B.A., is professor of medicine and immunology and chief of the Division of Cellular Therapy at Duke University. He is also associate director for clinical studies at the Duke Comprehensive Cancer Center and serves as PI of the Duke Center for Countermeasures Against Radiation. Dr. Chao is trained as a hematologist-oncologist and has focused his research on hematopoietic cell transplantation, graft-versus-host disease, and immune reconstitution in murine models and in patients. Dr. Chao has served on several national committees, as a member of the Board of Scientific Counselors of NHLBI, and on an NIH study section. He is also the co-chair of the Radiation Injury Treatment Network. (October 31, 2013) |
 |
Sharon C. Kiely, M.D., M.P.M., is medical director for quality and patient safety at Allegheny General Hospital in Pittsburgh and associate professor of medicine at Drexel University School of Medicine. She has served on the United Network for Organ Sharing board of directors as well as the HHS Secretary’s Advisory Committee on Xenotransplantation. She is a specialist in internal medicine and has focused her clinical, research, and volunteer efforts on juvenile diabetes, medical education, and care to underserved populations, including those with HIV/AIDS. (October 31, 2010) |
 |
William M. McLin, M.Ed., is president and CEO of the Asthma and Allergy Foundation of America (AAFA). Before coming to AAFA, he served as director of government relations and executive vice president during his 20-year tenure with the Epilepsy Foundation of America. He also provided interim executive oversight services to numerous nonprofit organizations. Mr. McLin has held key positions with the National Health Council, the American Society of Association Executives, the President’s Committee for Employment of People with Disabilities, and the Public Advisory Roundtable of the American Thoracic Society. (October 31, 2012) |
 |
Marc E. Rothenberg, M.D., Ph.D., is professor of pediatrics and director of the Division of Allergy and Immunology at Cincinnati Children’s Hospital Medical Center. He also serves as director for the Cincinnati Center for Eosinophilic Disorders. His research focuses on molecular mechanisms of allergic inflammation. He studies the genes and molecules involved in allergic responses, cellular and molecular immunology, and the development and analysis of genetically engineered and antigen-driven models of allergic disease in mice. He also conducts translational clinical trials. (October 31, 2010) |
 |
David S. Wilkes, M.D., is Dr. Calvin H. English Professor of Medicine, Microbiology, and Immunology at the Indiana University School of Medicine. A pulmonary and critical care physician, he is also the director for the Center for Immunobiology at Indiana. He researches the immunopathogenesis of lung transplant rejection with a focus on alloimmune-induced autoimmunity in lung transplant recipients. Dr. Wilkes has served as an NIH study section member and co-chaired the NIH-sponsored Workshop Summary on Lung Transplantation: Opportunities for Research and Clinical Advancement. (October 31, 2010) |
Microbiology and Infectious Diseases (DMID) Subcommittee
| Photo |
Name, Biosketch, and Date Term Ends |
 |
Ann M. Arvin, M.D., is Lucile Salter Packard Professor of Pediatrics and professor of microbiology and immunology at Stanford University School of Medicine. She also serves as vice provost and dean of research at Stanford University. Her principal research interests are the human herpesviruses and childhood viral diseases and vaccines. Dr. Arvin conducted early studies of varicella-zoster virus vaccine that is now licensed for the prevention of chickenpox and zoster. She has served on many national committees, including the NIH Collaborative Antiviral Study Group and the National Vaccine Advisory Committee to the secretary, HHS. (October 31, 2011) |
 |
N. Regina Rabinovich, M.D., M.P.H., is director of infectious diseases, Global Health Program at the Bill and Melinda Gates Foundation. She directs the development and implementation of drug and vaccine strategies to prevent, treat, and control diseases relevant to global health, such as malaria, pneumonia, diarrhea, and human papillomavirus (HPV). Dr. Rabinovich is on the board of several organizations involved in global health and infectious diseases, including the National Center for Infectious Diseases at CDC, African Malaria Network Trust, and the Institute for OneWorld Health. (October 31, 2011) |
 |
George Siber, M.D., is executive chairman of Genocea Biosciences and director of Selecta Biosciences in Boston. Dr. Siber also serves as professor of medicine and special advisor, Massachusetts Biologic Laboratories at the University of Massachusetts Medical School, as well as adjunct professor of medicine in the Department of International Health, Bloomberg School of Public Health at The Johns Hopkins University. Previously, Dr. Siber was executive vice president and chief scientific officer of Wyeth Vaccines Research, overseeing the development and approval of six vaccines including Prevenar, the first pneumococcal conjugate vaccine. (October 31, 2013)
|
 |
Samuel L. Stanley, Jr., M.D., is vice chancellor for research at Washington University in St. Louis, director of the Midwest Regional Center of Excellence in Biodefense and Emerging Infectious Diseases, and professor in the Departments of Medicine and Molecular Microbiology at Washington University School of Medicine, St. Louis. His research interests include understanding the molecular basis for the pathogenesis of enteric infections, characterizing protective components of innate immunity to infectious disease threats, and identifying markers for genetic susceptibility to disease. (October 31, 2012) |
 |
Christopher M. Walker, Ph.D., is director of the Center for Vaccines and Immunity at the Nationwide Children’s Hospital in Columbus, Ohio, and professor of pediatrics and molecular virology, immunology, and medical genetics at Ohio State University. His primary research interest is regulating immune responses in persistent virus infections with an emphasis on hepatitis C virus. Dr. Walker serves as U.S. chair of the Hepatitis Panel, U.S.-Japan Cooperative Medical Sciences Program and is on the editorial advisory board of the Journal of Experimental Medicine. (October 31, 2012) |
 |
Richard I. Whitley, M.D., is professor of pediatrics, microbiology, medicine, and neurosurgery at the University of Alabama at Birmingham (UAB) and the Loeb Eminent Scholar Chair in Pediatrics. He directs the Division of Pediatric Infectious Diseases and is vice-chair of the Department of Pediatrics. Dr. Whitley co-directs the UAB Center for Emerging Infections and Emergency Preparedness. His research focuses on studying antiviral agents for unmet medical needs, developing antiviral drugs to treat orthopox infections, and engineering herpes simplex virus to treat brain tumors. He is the project director of the NIAID Collaborative Antiviral Study Group. (October 31, 2012) |
| |
Ex officio members:
- Mitchell B. Cohen, M.D., Director, Coordinating Center for Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention
- Bruce G. Gellin, M.D., M.P.H., Director, National Vaccine Program Office, Office of Public Health and Science, Office of the Assistant Secretary for Health, DHHS
- Major General James K. Gilman, M.D., Commanding General, U.S. Army Medical Research and Materiel Command (USAMRMC) and Fort Detrick
- Colonel Kent E. Kester, M.D., Commander, Walter Reed Army Institute of Research
|
For more information, see the Advisory Council portal. |
Look It Up
See the Glossary for more terms. |
|
